Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-15 Wasman Jane Director Grant or award +5,750 18,250
2025-05-23 Wasman Jane Director Grant or award +2,500 12,500
2025-05-23 Wasman Jane Director Grant or award · Stock Option (Right to Buy) +3,000 3,000
2024-05-25 Wasman Jane Director Grant or award +25,000 100,000
2024-05-25 Wasman Jane Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-05-26 Wasman Jane Director Grant or award +25,000 75,000
2023-05-26 Wasman Jane Director Grant or award · Stock Option (Right to Buy) +30,000 30,000

Page 1 of 1 · 7 trades